Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 109,272,143
- Total 13F shares
- 1,309,286
- Share change
- -115,021
- Total reported value
- $1,297,302
- Price per share
- $0.99
- Number of holders
- 41
- Value change
- -$118,709
- Number of buys
- 15
- Number of sells
- 13
Report period
Q2 2024
Institutions
41
Top holders
10
ONCY full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
0.32%
|
348,313
|
$369,212 | — | 31 Mar 2024 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
201,452
|
$213,539 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
162,765
|
$172,531 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
83,598
|
$88,614 | — | 31 Mar 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.06%
|
62,764
|
$67,000 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
61,033
|
$65,000 | — | 31 Mar 2024 | |
| CIBC WORLD MARKET INC. |
13F
|
Company |
0.05%
|
58,150
|
$62,000 | — | 31 Mar 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
51,889
|
$55,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
41,942
|
$44,458 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
40,887
|
$43,340 | — | 31 Mar 2024 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.04%
|
40,000
|
$42,400 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.03%
|
37,320
|
$38,589 | — | 31 Mar 2024 | |
| Ausdal Financial Partners, Inc. |
13F
|
Company |
0.02%
|
26,000
|
$27,560 | — | 31 Mar 2024 | |
| BRAVE ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
25,000
|
$26,790 | — | 31 Mar 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
18,009
|
$19,090 | — | 31 Mar 2024 | |
| HEADINVEST, LLC |
13F
|
Company |
0.02%
|
16,534
|
$17,526 | — | 31 Mar 2024 | |
| C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors |
13F
|
Company |
0.01%
|
15,000
|
$15,900 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
13,339
|
$14,160 | — | 31 Mar 2024 | |
| Cantonale Vaudoise Banque |
13F
|
Individual |
0.01%
|
11,900
|
$13,000 | — | 31 Mar 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
11,816
|
$12,525 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
11,697
|
$13,430 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
11,500
|
$12,190 | — | 31 Mar 2024 | |
| Kingsview Wealth Management, LLC |
13F
|
Company |
0.01%
|
11,000
|
$11,660 | — | 31 Mar 2024 | |
| PFG Investments, LLC |
13F
|
Company |
0.01%
|
10,500
|
$11,130 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.01%
|
10,257
|
$10,872 | — | 31 Mar 2024 | |
| PROFESSIONAL ADVISORY SERVICES INC |
13F
|
Company |
0.01%
|
10,000
|
$11,000 | — | 31 Mar 2024 | |
| Cedar Mountain Advisors, LLC |
13F
|
Company |
0.01%
|
5,651
|
$5,990 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
4,401
|
$4,665 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
3,294
|
$4,677 | — | 31 Mar 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
2,500
|
$2,650 | — | 31 Mar 2024 | |
| CWM, LLC |
13F
|
Company |
0%
|
2,325
|
$2,000 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,164
|
$1,234 | — | 31 Mar 2024 | |
| JNBA Financial Advisors |
13F
|
Company |
0%
|
210
|
$223 | — | 31 Mar 2024 | |
| Credential Qtrade Securities Inc. |
13F
|
Company |
0%
|
52
|
$55 | — | 31 Mar 2024 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0%
|
31
|
$33 | — | 31 Mar 2024 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0%
|
5
|
$5 | — | 31 Mar 2024 |
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2024
As of 30 Jun 2024,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,309,286 shares.
The largest 10 holders included
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, SEEDS INVESTOR LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, COMMONWEALTH EQUITY SERVICES, LLC, Royal Bank of Canada, CIBC WORLD MARKET INC., GEODE CAPITAL MANAGEMENT, LLC, and Long Focus Capital Management, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
35
Q2 2024 holders
41
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.